Literature DB >> 15690483

Chronological development of elevated aminotransferases in a nonalcoholic population.

Ayako Suzuki1, Paul Angulo, James Lymp, Jennifer St Sauver, Ayako Muto, Toshihide Okada, Keith Lindor.   

Abstract

The incidence and risk factors of nonalcoholic fatty liver disease (NAFLD) have never been prospectively determined. To determine the frequency and risk factors of NAFLD and chronological ordering between NAFLD, weight gain, and features of insulin resistance, a historical cohort study was conducted in a Japanese workplace. A cohort free of previous liver injury, alcohol consumption of more than 140 g/wk, and hepatitis B or C infection (529 of 1537 subjects), and a subcohort of 287 subjects free of insulin resistance-related features were identified. Elevated aminotransferases in nonalcoholics were used as a surrogate for NAFLD. High aminotransferases together with weight gain of more than 2 kg and insulin resistance-related features in the subcohort were sought for up to 5 years. The incidence of high aminotransferases was 31 per 1000 person-years (71 events). A significant interaction occurred between age and sex in the development of high aminotransferases. In subjects younger than age 40 years, male sex (hazard ratio [HR]: 4.6), elevated body mass index (HR: 2.1), hypertension (HR: 2.6), and low high-density lipoprotein cholesterol (HR: 2.8) increased the risk of high aminotransferases, whereas age (HR: 0.6 for each 5 years) decreased the risk. In subjects older than age 40 years, glucose intolerance (HR: 5.3) was the only significant risk factor. In the subcohort, weight gain preceded high aminotransferases and other insulin resistance-related features, which appeared sequentially in order of low high-density lipoprotein cholesterol, hypertriglyceridemia/hypertransaminasemia/hypertension, and glucose intolerance. In conclusion, this cohort study clearly showed chronological ordering and an association between development of elevated aminotransferases and risk factors of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15690483     DOI: 10.1002/hep.20543

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

1.  Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress.

Authors:  Simona Bo; Roberto Gambino; Marilena Durazzo; Sabrina Guidi; Elisa Tiozzo; Federica Ghione; Luigi Gentile; Maurizio Cassader; Gian Franco Pagano
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 2.  Carotenoids and non-alcoholic fatty liver disease.

Authors:  Bahiddin Yilmaz; Kazim Sahin; Hande Bilen; Ibrahim H Bahcecioglu; Birdal Bilir; Sara Ashraf; Karim J Halazun; Omer Kucuk
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

3.  The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease.

Authors:  Kirsten-Berit Linhart; Katharina Glassen; Teresa Peccerella; Rüdiger Waldherr; Heinz Linhart; Helmut Bartsch; Helmut K Seitz
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

4.  How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool.

Authors:  Varun Takyar; Anand Nath; Andrea Beri; Ahmed M Gharib; Yaron Rotman
Journal:  Hepatology       Date:  2017-07-27       Impact factor: 17.425

Review 5.  Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.

Authors:  Kareem Hassan; Varun Bhalla; Mohammed Ezz El Regal; H Hesham A-Kader
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

6.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

7.  Association between puberty and features of nonalcoholic fatty liver disease.

Authors:  Ayako Suzuki; Manal F Abdelmalek; Jeffrey B Schwimmer; Joel E Lavine; Ann O Scheimann; Aynur Unalp-Arida; Katherine P Yates; Arun J Sanyal; Cynthia D Guy; Anna Mae Diehl
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 11.382

Review 8.  Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.

Authors:  Christine C Hsu; Erik Ness; Kris V Kowdley
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

Review 9.  Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature.

Authors:  Masafumi Ono; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

10.  Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Authors:  Mazen Noureddin; Katherine P Yates; Ivana A Vaughn; Brent A Neuschwander-Tetri; Arun J Sanyal; Arthur McCullough; Raphael Merriman; Bilal Hameed; Edward Doo; David E Kleiner; Cynthia Behling; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.